Xenogeneic mouse anti-human NK cytotoxicity is mediated via perform

Xenotransplantation

Volumn 4, Issue 2, 1997, Pages 78-84

  Smyth, Mark J ^a   Thia, Kevin Y T ^b   Kershaw, Michael H ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b Austin Hospital ^*

Author keywords

Fas ligand; Human; Mouse; Natural killer; Perforin; Xenotransplantation

Indexed keywords

EID: 0002510207     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1997.tb00169.x     Document Type: Article

References (32)

1. KAGI D, LEDERMANN B, BURKI K, SEILER P, ODERMATT B, OLSEN KJ, PODACK ER, ZINKERNAGEL RM, GARTNER H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994:369:31.
2. WALSH CM, MATLOUBIAN M, LIU C-C, VEDA R, KURAHARA CG, CHRISTENSEN JL, HUANG MTF, YOUNG JD-E, AHMED R, CLARK WR. Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA 1994:91:10854.
3. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993:177:195.
4. SUDA T, NAGATA S. Purification and characterisation of the Fas-ligand that induces apoptosis. J Exp Med 1994: 179:873.
5. KAGI D, VIGNAUX F, LEDERMANN B, BURKI K, DEPRAETERE V, NAGATA S, HENGARTNER H, GOLSTEIN P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994:265:528.
6. INVERARDI L, SAMAJA M, MOTTERLINI R, MANGILI F, BENDER JR, PARDI R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J. Immunol. 1992:149:1416.
7. BACH FH, WINKLER H, FERRAN C, HANCOCK WW, ROBSON SC. Delayed xenograft rejection. Immunol Today 1996:17:379.
8. BLAKELY ML, VAN DER WERF WJ, BERNDT MC, DALMASSO AP, BACH FH, HANCOCK WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994:58:1059.
9. SEEBACH JD, YAMADA K, MCMORROW IM, SACHS DH, DERSIMONIAN HD. Xenogeneic human anti-pig cytotoxicity mediated by natural killer cells. Xenotransplantation 1996:3:188.
10. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 1994:24:3068.
11. SINGER G, ABBAS AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994:1:365.
12. RUSSELL JH, RUSH B, WEAVER C, WANG R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993:90: 4409.
13. ARASE H, ARASE N, SAITO T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 1995: 181:1235.
14. ROBERTSON MJ, MANLEY TJ, PICHERT G, CAMERON C, COCHRAN KJ, LEVINE H, RITZ J. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymphoma 1995: 17:51.
15. TANAKA M, SUDA T, HAZE K, NAKAMURA N, SATO K, KIMURA F, MOTOYOSHI K, MIZUKI M, TAGAWA S, OHGA S, HATAKE K, DRUMMOND AH, NAGATA S. Fas ligand in human serum. Nat Med 1996:2:317.
16. EISCHEN CM, SCHILLING JD, LYNCH DH, KRAMMER PH, LEIBSON PJ. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 1996:156:2693.
17. OSHIMI Y, ODA S, HONDA Y, NAGATA S, MIYAZAKI S. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 1996:157:2909.
18. TRINCHIERI G, BAUMAN P, DE MARCHI M, TOKES Z. Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell. J Immunol 1975 :115:249.
19. SMYTH MJ, SUTTON VR, KERSHAW MH, TRAPANI JA. Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways. Transplantation 1996: 62:1529.
20. COHEN P, EISENBERG RA. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991:9:243.
21. KIRK AD, HEINLE JS, MAULT J, SANFILIPPO F. Ex vivo characterisation of human anti-porcine hyperacute cardiac rejection. Transplantation 1993:56:785.
22. INVERARDI L, PARDI R. Early events in cell-mediated recognition of vascularized xenografts: Cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 1994:141:71.
23. GOODMAN DJ, VON-ALBERTINI M, WILSON A, MILLAN MT, BACH FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996: 61:763.
24. MALYGUINE AM, SAADI S, PLATT JL, DAWSON JR. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation 1996:61:161.
25. KIRK AD, LI R, KINCH MS, ABERNETHY KA, DOYLE C, BOLLINGER RR. The human anti-porcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation 1993:55:924.
26. SULICA A, METES D, GHERMAN M, WHITESIDE TL, HERBERMAN RB. Divergent effects of Fc gamma RIIIA ligands on the functional activities of human natural killer cells in vitro. Eur J Immunol 1996:26:1199.
27. HORIUCHI A, ABE Y, MIYAKE M, KIMURA K, HITSUMOTO Y, TAKEUCHI N, KIMURA S. Role of membrane-associated lymphotoxin (mLT) in the killing activity of lymphokine-activated killer (LAK) cells towards various tumour cell lines. Clin Exp Immunol 1994:96:152.
28. SALCEDO M, HOGLUND P, LJUNGGREN HG. Natural killer cell interaction with murine allogeneic MHC class I molecules. Transplantation 1995:60:281.
29. LANIER LL. The role of natural killer cells in transplantation. Curr Opin Immunol 1995:7:626.
30. SMITH HR, KARLHOFER FM, YOKOYAMA WM. Ly-49 multigene family expressed by IL-2-activated NK cells. J Immunol 1994:153:1068.
31. BRENNAN J, MAGER D, JEFFRIES W, TAKEI F. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 1994:180:2287.
32. BEZOUSKA K, YUEN CT, O'BRIEN J, CHILDS RA, CHAI W, LAWSON AM, DRBAL K, FISEROVA A, POSPISIL M, FEIZI T. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994:372:150.